Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma

Francesca Rizzo, Antonio Rinaldi, Giovanna Marchese, Elena Coviello, Assunta Sellitto, Angela Cordella, Giorgio Giurato, Giovanni Nassa, Maria Ravo, Roberta Tarallo, Luciano Milanesi, Annarita Destro, Guido Torzilli, Massimo Roncalli, Luca Di Tommaso, A. Weisz

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is the result of a stepwise process, often beginning with development within a cirrhotic liver of premalignant lesions, morphologically characterized by low- (LGDN) and high-grade (HGDN) dysplastic nodules. PIWI-interacting RNAs (piRNAs) are small noncoding RNAs (sncRNAs), 23-35 nucleotide-long, exerting epigenetic and post-transcriptional regulation of gene expression. Recently the PIWI-piRNA pathway, best characterized in germline cells, has been identified also in somatic tissues, including stem and cancer cells, where it influences key cellular processes. Small RNA sequencing was applied to search for liver piRNAs and to profile their expression patterns in cirrhotic nodules (CNs), LGDN, HGDN, early HCC and progressed HCC (pHCC), analyzing 55 samples (14 CN, 9 LGDN, 6 HGDN, 6 eHCC and 20 pHCC) from 17 patients, aiming at identifying possible relationships between these sncRNAs and liver carcinogenesis. We identified a 125 piRNA expression signature that characterize HCC from matched CNs, correlating also to microvascular invasion in HCC. Functional analysis of the predicted RNA targets of deregulated piRNAs indicates that these can target key signaling pathways involved in hepatocarcinogenesis and HCC progression, thereby affecting their activity. Interestingly, 24 piRNAs showed specific expression patterns in dysplastic nodules, respect to cirrhotic liver and/or pHCC. The results demonstrate that the PIWI-piRNA pathway is active in human liver, where it represents a new player in the molecular events that characterize hepatocarcinogenesis, from early stages to pHCC. Furthermore, they suggest that piRNAs might be new disease biomarkers, useful for differential diagnosis of dysplastic and neoplastic liver lesions.

Original languageEnglish
Pages (from-to)54650-54661
Number of pages12
JournalOncotarget
Volume7
Issue number34
DOIs
Publication statusPublished - 2016

Fingerprint

Small Untranslated RNA
Hepatocellular Carcinoma
RNA
Liver
Small Interfering RNA
RNA Sequence Analysis
Neoplastic Stem Cells
Gene Expression Regulation
Epigenomics
Carcinogenesis
Differential Diagnosis
Nucleotides
Biomarkers

Keywords

  • Hepatocarcinogenesis
  • Hepatocellular carcinoma
  • PiRNAs
  • Small non-coding RNA
  • SmallRNA-seq

ASJC Scopus subject areas

  • Oncology

Cite this

Rizzo, F., Rinaldi, A., Marchese, G., Coviello, E., Sellitto, A., Cordella, A., ... Weisz, A. (2016). Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Oncotarget, 7(34), 54650-54661. https://doi.org/10.18632/oncotarget.10567

Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. / Rizzo, Francesca; Rinaldi, Antonio; Marchese, Giovanna; Coviello, Elena; Sellitto, Assunta; Cordella, Angela; Giurato, Giorgio; Nassa, Giovanni; Ravo, Maria; Tarallo, Roberta; Milanesi, Luciano; Destro, Annarita; Torzilli, Guido; Roncalli, Massimo; Di Tommaso, Luca; Weisz, A.

In: Oncotarget, Vol. 7, No. 34, 2016, p. 54650-54661.

Research output: Contribution to journalArticle

Rizzo, F, Rinaldi, A, Marchese, G, Coviello, E, Sellitto, A, Cordella, A, Giurato, G, Nassa, G, Ravo, M, Tarallo, R, Milanesi, L, Destro, A, Torzilli, G, Roncalli, M, Di Tommaso, L & Weisz, A 2016, 'Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma', Oncotarget, vol. 7, no. 34, pp. 54650-54661. https://doi.org/10.18632/oncotarget.10567
Rizzo, Francesca ; Rinaldi, Antonio ; Marchese, Giovanna ; Coviello, Elena ; Sellitto, Assunta ; Cordella, Angela ; Giurato, Giorgio ; Nassa, Giovanni ; Ravo, Maria ; Tarallo, Roberta ; Milanesi, Luciano ; Destro, Annarita ; Torzilli, Guido ; Roncalli, Massimo ; Di Tommaso, Luca ; Weisz, A. / Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 34. pp. 54650-54661.
@article{103f1c301052468192b776fd7123e66b,
title = "Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is the result of a stepwise process, often beginning with development within a cirrhotic liver of premalignant lesions, morphologically characterized by low- (LGDN) and high-grade (HGDN) dysplastic nodules. PIWI-interacting RNAs (piRNAs) are small noncoding RNAs (sncRNAs), 23-35 nucleotide-long, exerting epigenetic and post-transcriptional regulation of gene expression. Recently the PIWI-piRNA pathway, best characterized in germline cells, has been identified also in somatic tissues, including stem and cancer cells, where it influences key cellular processes. Small RNA sequencing was applied to search for liver piRNAs and to profile their expression patterns in cirrhotic nodules (CNs), LGDN, HGDN, early HCC and progressed HCC (pHCC), analyzing 55 samples (14 CN, 9 LGDN, 6 HGDN, 6 eHCC and 20 pHCC) from 17 patients, aiming at identifying possible relationships between these sncRNAs and liver carcinogenesis. We identified a 125 piRNA expression signature that characterize HCC from matched CNs, correlating also to microvascular invasion in HCC. Functional analysis of the predicted RNA targets of deregulated piRNAs indicates that these can target key signaling pathways involved in hepatocarcinogenesis and HCC progression, thereby affecting their activity. Interestingly, 24 piRNAs showed specific expression patterns in dysplastic nodules, respect to cirrhotic liver and/or pHCC. The results demonstrate that the PIWI-piRNA pathway is active in human liver, where it represents a new player in the molecular events that characterize hepatocarcinogenesis, from early stages to pHCC. Furthermore, they suggest that piRNAs might be new disease biomarkers, useful for differential diagnosis of dysplastic and neoplastic liver lesions.",
keywords = "Hepatocarcinogenesis, Hepatocellular carcinoma, PiRNAs, Small non-coding RNA, SmallRNA-seq",
author = "Francesca Rizzo and Antonio Rinaldi and Giovanna Marchese and Elena Coviello and Assunta Sellitto and Angela Cordella and Giorgio Giurato and Giovanni Nassa and Maria Ravo and Roberta Tarallo and Luciano Milanesi and Annarita Destro and Guido Torzilli and Massimo Roncalli and {Di Tommaso}, Luca and A. Weisz",
year = "2016",
doi = "10.18632/oncotarget.10567",
language = "English",
volume = "7",
pages = "54650--54661",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "34",

}

TY - JOUR

T1 - Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma

AU - Rizzo, Francesca

AU - Rinaldi, Antonio

AU - Marchese, Giovanna

AU - Coviello, Elena

AU - Sellitto, Assunta

AU - Cordella, Angela

AU - Giurato, Giorgio

AU - Nassa, Giovanni

AU - Ravo, Maria

AU - Tarallo, Roberta

AU - Milanesi, Luciano

AU - Destro, Annarita

AU - Torzilli, Guido

AU - Roncalli, Massimo

AU - Di Tommaso, Luca

AU - Weisz, A.

PY - 2016

Y1 - 2016

N2 - Hepatocellular carcinoma (HCC) is the result of a stepwise process, often beginning with development within a cirrhotic liver of premalignant lesions, morphologically characterized by low- (LGDN) and high-grade (HGDN) dysplastic nodules. PIWI-interacting RNAs (piRNAs) are small noncoding RNAs (sncRNAs), 23-35 nucleotide-long, exerting epigenetic and post-transcriptional regulation of gene expression. Recently the PIWI-piRNA pathway, best characterized in germline cells, has been identified also in somatic tissues, including stem and cancer cells, where it influences key cellular processes. Small RNA sequencing was applied to search for liver piRNAs and to profile their expression patterns in cirrhotic nodules (CNs), LGDN, HGDN, early HCC and progressed HCC (pHCC), analyzing 55 samples (14 CN, 9 LGDN, 6 HGDN, 6 eHCC and 20 pHCC) from 17 patients, aiming at identifying possible relationships between these sncRNAs and liver carcinogenesis. We identified a 125 piRNA expression signature that characterize HCC from matched CNs, correlating also to microvascular invasion in HCC. Functional analysis of the predicted RNA targets of deregulated piRNAs indicates that these can target key signaling pathways involved in hepatocarcinogenesis and HCC progression, thereby affecting their activity. Interestingly, 24 piRNAs showed specific expression patterns in dysplastic nodules, respect to cirrhotic liver and/or pHCC. The results demonstrate that the PIWI-piRNA pathway is active in human liver, where it represents a new player in the molecular events that characterize hepatocarcinogenesis, from early stages to pHCC. Furthermore, they suggest that piRNAs might be new disease biomarkers, useful for differential diagnosis of dysplastic and neoplastic liver lesions.

AB - Hepatocellular carcinoma (HCC) is the result of a stepwise process, often beginning with development within a cirrhotic liver of premalignant lesions, morphologically characterized by low- (LGDN) and high-grade (HGDN) dysplastic nodules. PIWI-interacting RNAs (piRNAs) are small noncoding RNAs (sncRNAs), 23-35 nucleotide-long, exerting epigenetic and post-transcriptional regulation of gene expression. Recently the PIWI-piRNA pathway, best characterized in germline cells, has been identified also in somatic tissues, including stem and cancer cells, where it influences key cellular processes. Small RNA sequencing was applied to search for liver piRNAs and to profile their expression patterns in cirrhotic nodules (CNs), LGDN, HGDN, early HCC and progressed HCC (pHCC), analyzing 55 samples (14 CN, 9 LGDN, 6 HGDN, 6 eHCC and 20 pHCC) from 17 patients, aiming at identifying possible relationships between these sncRNAs and liver carcinogenesis. We identified a 125 piRNA expression signature that characterize HCC from matched CNs, correlating also to microvascular invasion in HCC. Functional analysis of the predicted RNA targets of deregulated piRNAs indicates that these can target key signaling pathways involved in hepatocarcinogenesis and HCC progression, thereby affecting their activity. Interestingly, 24 piRNAs showed specific expression patterns in dysplastic nodules, respect to cirrhotic liver and/or pHCC. The results demonstrate that the PIWI-piRNA pathway is active in human liver, where it represents a new player in the molecular events that characterize hepatocarcinogenesis, from early stages to pHCC. Furthermore, they suggest that piRNAs might be new disease biomarkers, useful for differential diagnosis of dysplastic and neoplastic liver lesions.

KW - Hepatocarcinogenesis

KW - Hepatocellular carcinoma

KW - PiRNAs

KW - Small non-coding RNA

KW - SmallRNA-seq

UR - http://www.scopus.com/inward/record.url?scp=84983494313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983494313&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10567

DO - 10.18632/oncotarget.10567

M3 - Article

VL - 7

SP - 54650

EP - 54661

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -